| The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 B Vogel, M Acevedo, Y Appelman, CNB Merz, A Chieffo, GA Figtree, ... The Lancet 397 (10292), 2385-2438, 2021 | 729 | 2021 |
| ST-segment elevation myocardial infarction B Vogel, BE Claessen, SV Arnold, D Chan, DJ Cohen, E Giannitsis, ... Nature reviews Disease primers 5 (1), 39, 2019 | 324 | 2019 |
| Right ventricular dilation in hospitalized patients with COVID-19 infection E Argulian, K Sud, B Vogel, C Bohra, VP Garg, S Talebi, S Lerakis, ... Cardiovascular Imaging 13 (11), 2459-2461, 2020 | 239 | 2020 |
| Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ... European heart journal 43 (7), e17-e25, 2022 | 184 | 2022 |
| Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents S Sorrentino, G Giustino, R Mehran, AS Kini, SK Sharma, M Faggioni, ... Journal of the American College of Cardiology 69 (25), 3055-3066, 2017 | 140 | 2017 |
| Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions DN Kalkman, M Aquino, BE Claessen, U Baber, P Guedeney, ... European heart journal 39 (46), 4101-4108, 2018 | 105 | 2018 |
| Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention P Guedeney, BE Claessen, DN Kalkman, M Aquino, S Sorrentino, ... Journal of the American College of Cardiology 73 (19), 2401-2409, 2019 | 81 | 2019 |
| Non-atherosclerotic causes of acute coronary syndromes TM Waterbury, G Tarantini, B Vogel, R Mehran, BJ Gersh, R Gulati Nature Reviews Cardiology 17 (4), 229-241, 2020 | 79 | 2020 |
| Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019 | 76 | 2019 |
| Ticagrelor with or without aspirin after PCI: the TWILIGHT platelet substudy U Baber, MU Zafar, G Dangas, G Escolar, DJ Angiolillo, SK Sharma, ... Journal of the American College of Cardiology 75 (6), 578-586, 2020 | 71 | 2020 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 59 | 2019 |
| Reperfusion strategies in acute myocardial infarction and multivessel disease B Vogel, SR Mehta, R Mehran Nature Reviews Cardiology 14 (11), 665-678, 2017 | 56 | 2017 |
| Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse … MK Freynhofer, I Brozovic, V Bruno, S Farhan, B Vogel, G Jakl, M Willheim, ... Thrombosis and haemostasis 106 (08), 230-239, 2011 | 54 | 2011 |
| Associations between chronic kidney disease and outcomes with use of prasugrel versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary … U Baber, J Chandrasekhar, S Sartori, M Aquino, AS Kini, S Kapadia, ... JACC: Cardiovascular Interventions 10 (20), 2017-2025, 2017 | 50 | 2017 |
| Echocardiographic findings in patients with COVID-19 with significant myocardial injury K Sud, B Vogel, C Bohra, V Garg, S Talebi, S Lerakis, J Narula, E Argulian Journal of the American Society of Echocardiography 33 (8), 1054-1055, 2020 | 49 | 2020 |
| Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis P Guedeney, S Sorrentino, G Giustino, C Chapelle, S Laporte, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (3), 225-235, 2021 | 47 | 2021 |
| Sex differences among patients with high risk receiving ticagrelor with or without aspirin after percutaneous coronary intervention: a subgroup analysis of the TWILIGHT … B Vogel, U Baber, DJ Cohen, S Sartori, SK Sharma, DJ Angiolillo, ... JAMA cardiology 6 (9), 1032-1041, 2021 | 39 | 2021 |
| Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation B Vogel, S Farhan, S Hahne, I Kozanli, K Kalla, MK Freynhofer, R Jarai, ... European Heart Journal: Acute Cardiovascular Care 5 (4), 347-353, 2016 | 37 | 2016 |
| The Lancet Commission on women and cardiovascular disease: time for a shift in women's health R Mehran, B Vogel, R Ortega, R Cooney, R Horton The Lancet 393 (10175), 967-968, 2019 | 36 | 2019 |
| Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study S Farhan, MK Freynhofer, I Brozovic, V Bruno, B Vogel, I Tentzeris, ... Cardiovascular diabetology 15, 1-7, 2016 | 36 | 2016 |
Serdar FarhanZena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, NY, NYVerified email at mountsinai.org
